Two recent acquisition announcements - Ergomed and Instem - highlight a growing trend: private equity firms targeting undervalued UK life sciences companies.
Two recent acquisition announcements Ergomed and Instem highlight a growing trend: private equity firms targeting undervalued UK life sciences companies.
Amryt Pharma plc (LON:AMYT – Get Free Report)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 143 ($1.80) and traded as low as GBX 143 ($1.80). Amryt Pharma shares last traded at GBX 143 ($1.80), with a volume of […]
Amryt Pharma plc (LON:AMYT – Get Free Report) shares passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 143 ($1.80) and traded as low as GBX 143 ($1.80). Amryt Pharma shares last traded at GBX 143 ($1.80), with a volume of 90,727 […]
NICE recommends Amryt s Filsuvez treatment for epidermolysis bullosa pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.